This website is best viewed in IE9 and above. Please upgrade your browser.


Study Connect Homepage » Protocol

Find out when studies you're interested in open or close, and when new information is posted

Study ID ( Protocol Number ) CN002-003

If you would like to be contacted about this study by a doctor's office or clinic, please select a location and register below (if available).


No study locations were found within your desired distance. Please consider changing your distance limit above or subscribe to be alerted if new study location becomes available based on your original search criteria.

Alert me!

The above listing doesn't contain all study locations. For more information on participating countries & other details,please visit

Study Name

Multiple Ascending Dose Study of Intravenously Administered BMS-986168 in Patients With Progressive Supranuclear Palsy

Share this Study

Study Overview

The purpose of this study is to evaluate the safety and tolerability of multiple ascending intravenous infusions of BMS-986168 and to assess the pharmacodynamics of BMS-986168 on cerebrospinal fluid (CSF) extracellular tau (eTau) concentrations in patients with Progressive Supranuclear Palsy.

Full Study info
Find a Study

The study information provided here is a portion of what is available on Please visit for complete information about this and other clinical studies.

Have questions? Call 855-907-3286

The individuals who appear throughout this site are for illustrative purposes only. Except where noted, all persons
depicted are models and not real patients.

© 2016 Bristol-Myers Squibb Your use of the information on this site is subject to the terms of our
Legal Notice and Privacy Policy.